" class="no-js "lang="en-US"> NHS Archives - Page 13 of 13 - Medtech Alert
Sunday, September 28, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NHS’s £160M Accelerator Sites to Tackle Waiting Lists

The NHS has today announced a £160 million initiative to tackle waiting lists and develop […]

3D Heart Scans to Give Faster Treatment

People in England with coronary heart disease will be seen, diagnosed and treated up to […]

Digital Therapeutic Company Pioneer My mHealth Announces Successful Roll-Out of NHS-Approved Diabetes App to the Community of Kent

My mhealth announces its successful roll-out of their NHS-approved diabetes digital therapeutic platform, myDiabetes, as […]

Guy's and St Thomas' NHS Foundation Trust Selects Nuance Dragon Medical One As Part of a Large-Scale Digital Transformation

Nuance Communications, Inc. (NASDAQ: NUAN) today announced that Guy’s and St Thomas’ NHS Foundation Trust (the Trust) chose Nuance Dragon […]

Government Launches Covid-19 Antivirals Taskforce to Roll out Innovative Home Treatments This Autumn

A new Antivirals Taskforce has been launched by the government to identify treatments for UK […]

Next Phase of Vaccine Roll-Out

The UK is moving into the next phase of the COVID-19 vaccine programme as the […]

NHS Digital Selects Scandit’s Clinical Quality Computer Vision Technology to Digitise the Covid-Testing Process

Scandit, the leading technology platform for mobile computer vision and augmented reality (AR) solutions for […]

NHSX: AI at the Forefront of Efforts to Treat Coronavirus Patients

NHSX, a unit tasked with driving the digital transformation of care in the NHS, has […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more